Angiogenesis is highly related to infiltration of CD8+ T cells and regulation of other immunosuppressive cells [34], [35], and sorafenib has been shown to target the expression of VEGFR in the endothelial cells [11] and reduce the expression of VEGF in cancer cells [18]. This evidence concerns the gene CD8A and cancer.